✦ LIBER ✦

Randomized controlled trial of interferon- beta-1a in secondary progressive MS: Clinical results

Book ID: 121881629
Publisher: Lippincott Williams and Wilkins
Year: 2001
Tongue: English
Weight: 587 KB
Volume: 56
Category: Article
ISSN: 0028-3878
DOI: 10.1212/WNL.56.11.1496

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Benefit of interferon -1a on MSFC progre

Benefit of interferon -1a on MSFC progression in secondary progressive MS

✍ Cohen, J. A.; Cutter, G. R.; Fischer, J. S.; Goodman, A. D.; Heidenreich, F. R.; 📂 Article 📅 2002 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 207 KB

OPL101 SENTINEL: a randomized controlled

OPL101 SENTINEL: a randomized controlled trial of natalizumab (tysabri®) and interferon beta-1a (AVONEX®) in relapsing multiple sclerosis (MS). Magnetic resonance imaging (MRI) results

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 130 KB

Treatment of MS with interferon beta-1B-

Treatment of MS with interferon beta-1B-final clinical results of the betaseron trial

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 143 KB

Efficacy and tolerability of intramuscul

Efficacy and tolerability of intramuscular interferon beta-1a compared with subcutaneous interferon beta-1a in relapsing MS: results from PROOF

✍ Minagar, Alireza; Jock Murray, T. 📂 Article 📅 2008 🏛 Informa plc 🌐 English ⚖ 393 KB

New perspectives in treatment of MS: Res

New perspectives in treatment of MS: Results with recombinant Interferon beta-1a

✍ Lawrence Jacobs 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 135 KB

OPL102 Subgroup analyses from SENTINEL:

OPL102 Subgroup analyses from SENTINEL: a randomized controlled trial of natalizumab (Tysabri®) and interferon beta-1a (AVONEX®) in relapsing multiple sclerosis (MS)

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 130 KB